Skip to main content
Sign In

The Department of Dermatology deals with all aspects of the biology and diseases of the skin.

Department of Dermatology

Ongoing Clinical Research Studies

The University of Colorado Department of Dermatology has several ongoing clinical research studies. Click on the links below to learn more about the Investigators and their studies. For questions or additional information, please send an e-mail to

Seeking Patients to Participate: (Call 720-848-0556 if you’d like to participate or have questions)

PI: April Armstrong M.D., MPH
Study Contact: Jody Myers 720-848-0556
Title: A Study to Determine the Effect of Psoriasis Treatment on Cardiometabolic Disease
Length of Study: 1 year
Approved by COMIRB (Colorado Multiple Institutional Review Board) as study #13-2720

Purpose: The purpose of this study is to assess the effect of adalimumab (Humira), when compared to NB-UVB (narrow-band ultraviolet B) phototherapy or placebo (an inactive substance that may resemble an active substance but has no medical value) injection. The study will compare the effects of each on systemic inflammation and cardiovascular disease risk factors in subjects diagnosed with moderate to severe psoriasis.

Selected Other Ongoing Psoriasis Studies:

PI: April Armstrong M.D., MPH
Study Contact: Jody Myers 720-848-0556
Title: A 12-Week Multicenter Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of LY2439821 to Etanercept and Placebo in Patients with Moderate-to-Severe Plaque Psoriasis with a Long-Term Extension Period.
Length of Study: 5 years
Approved by WIRB (Western Institutional Review Board) as study # 20121432 (and as COMIRB #13-2723)

To find out more about dermatology clinical research studies, exactly what they are and how you can participate, click here.

Or contact us at:

Psoriasis Colorado Dermatology Clinical Research Unit
University of Colorado Anschutz Medical Campus
Mail Stop F703
Anschutz Cancer Pavilion
1665 Aurora Court, Room 3234
Aurora, CO 80045
Telephone: (720) 848-0556
Fax: (720) 848-0530